Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
Medical Decision Making
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Dolan, J. G.
Right arrow Articles by Bordley, D. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dolan, J. G.
Right arrow Articles by Bordley, D. R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ISONIAZID
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Isoniazid Prophylaxis

The Importance of Individual Values

James G. Dolan, MD

Donald R. Bordley, MD

To provide insight into the decision whether to use isoniazid prophylaxis in uncomplicated cases of positive tuberculin tests, the authors conducted a multicriteria decision analysis using the analytic hierarchy process. If reducing the chance of developing active tuberculosis is considered at least slightly more important than avoiding isoniazid-related side effects, isoniazid prophylaxis is the better strategy for all patients. If avoiding isoniazid-related side effects is considered at least slightly more important, no prophylaxis is the better strategy for all patients. If these two considerations are judged equally important, the better strategy depends on patient age, the anticipated effectiveness of isoniazid prophylaxis, and whether or not the patient is a recent tuberculin convertor. The tradeoff between avoiding active tuberculosis and avoiding isoniazid-related side effects is the most important factor in the decision regarding the proper management of patients with positive tuberculin tests. These results emphasize the importance of taking an individualized approach to the management of these patients. Key words: decision analysis; isoniazid; tuberculosis; decision mak ing; multicriteria decision analysis; analytic hierarchy process. (Med Decis Making 1994; 14:1-8)

Medical Decision Making, Vol. 14, No. 1, 1-8 (1994)
DOI: 10.1177/0272989X9401400101


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
InterfacesHome page
M. Liberatore, R. Nydick, C. Daskalakis, E. Kunkel, J. Cocroft, and R. Myers
Helping Men Decide About Scheduling a Prostate Cancer Screening Exam
Interfaces, May 1, 2009; 39(3): 209 - 217.
[Abstract] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
M. Peralta-Carcelen, C. A. Fargason Jr, D. Coston, and J. G. Dolan
Preferences of Pregnant Women and Physicians for 2 Strategies for Prevention of Early-Onset Group B Streptococcal Sepsis in Neonates
Arch Pediatr Adolesc Med, July 1, 1997; 151(7): 712 - 718.
[Abstract] [PDF]